摘要
In the aging populations of China,there is an increasing prevalence of various types of bradycardias that require pacing therapy.In 1958,the first transvenous pacemaker(TVPM)was implanted at Karolinska Hospital in Sweden,which unveiled the era of cardiac pacing therapy.[1]A TVPM includes transvenous electrodes and a pulse gener-ator that is implanted subcutaneously.Despite its obvious benefits,the complication rate associated with TVPM could be as high as 10%.
